Capital Performance Advisors »

Pyxis Oncology shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $520 142 3.67

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
Dimensional Etf Trust World Ex Us Core (DFAX)
Amazon (AMZN)

View all positions for Capital Performance Advisors

Top funds holding Pyxis Oncology

Deep Track Capital
Laurion Capital Management
BlackRock
BlackRock
Balyasny Asset Management
Vanguard Group
Ikarian Capital
Blue Owl Capital Holdings
Geode Capital Management
Standard Life Aberdeen
Stempoint Capital
State Street Corporation
Perceptive Advisors
Superstring Capital Management
683 Capital Management

View all funds holding Pyxis Oncology